Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

ART in low-resource settings: how to do more with less.

Koole O, Colebunders R.

Lancet. 2010 Aug 7;376(9739):396-8. doi: 10.1016/S0140-6736(10)61020-3. Epub 2010 Jul 15. No abstract available.

PMID:
20638119
2.

The real challenges for scaling up ART in sub-Saharan Africa.

Van Damme W, Kober K, Laga M.

AIDS. 2006 Mar 21;20(5):653-6. No abstract available.

PMID:
16514294
3.

Antiretroviral therapy in low-resource settings.

Cainelli F, Lanzafame M, Vento S.

Lancet. 2010 Oct 23;376(9750):1392. doi: 10.1016/S0140-6736(10)61957-5. No abstract available.

PMID:
20971363
4.

Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.

Toro PL, Katyal M, Carter RJ, Myer L, El-Sadr WM, Nash D, Abrams EJ; MTCT-Plus Initiative.

AIDS. 2010 Feb 20;24(4):515-24. doi: 10.1097/QAD.0b013e3283350ecd.

PMID:
19996939
5.

Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration.

Arrivé E, Kyabayinze DJ, Marquis B, Tumwesigye N, Kieffer MP, Azondekon A, Wemin L, Fassinou P, Newell ML, Leroy V, Abrams EJ, Cotton M, Boulle A, Mbori-Ngacha D, Dabis F; KIDS-ART-LINC Collaboration.

Int J Epidemiol. 2008 Jun;37(3):474-80. Epub 2007 Nov 12. No abstract available.

PMID:
17998240
6.

Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens.

Shannon K, Kaida A, Rachlis B, Lloyd-Smith E, Gray G, Strathdee SA.

AIDS. 2008 Sep 12;22(14):1705-7. doi: 10.1097/QAD.0b013e328308de0e. No abstract available.

PMID:
18753938
7.

Directly observed therapy for HIV/tuberculosis co-infection.

Lurie MN, Carter EJ, Cohen J, Flanigan TP.

Lancet Infect Dis. 2004 Mar;4(3):137-8. No abstract available.

PMID:
14998498
8.

Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings.

Phillips AN, Pillay D, Garnett G, Bennett D, Vitoria M, Cambiano V, Lundgren J.

AIDS. 2011 Mar 27;25(6):843-50. doi: 10.1097/QAD.0b013e328344037a.

PMID:
21192233
9.

Predicting the failure of 3 by 5.

Brown RC, Brown JE.

Lancet. 2005 Jul 9-15;366(9480):117-8. No abstract available.

PMID:
16005323
10.

Will ART rollout in Africa drive an epidemic of drug resistant HIV?

Hastings IM, Lalloo D, Khoo SH.

AIDS. 2006 Jun 12;20(9):1354-6; author reply 1356-7. No abstract available.

PMID:
16816578
11.

Predicting the failure of 3 by 5.

Harries AD.

Lancet. 2005 Jul 9-15;366(9480):117. No abstract available.

PMID:
16005322
12.

HIV-infected women in ART programmes.

Myer L, Morroni C, Nachega J, Cooper D.

Lancet. 2005 Feb 19-25;365(9460):655-6. No abstract available.

PMID:
15721468
13.

Antiretroviral drug resistance in resource-limited settings.

Richman DD.

Lancet. 2012 Oct 6;380(9849):1210-1. doi: 10.1016/S0140-6736(12)61188-X. Epub 2012 Jul 23. No abstract available.

PMID:
22828483
14.

The marriage of science and optimized HIV care in resource-limited settings.

Calmy A, Pizzocolo C, Pizarro L, Brücker G, Murphy R, Katlama C; Strategies in Resource-Limited Settings Working Group.

AIDS. 2008 Nov 12;22(17):2227-30. doi: 10.1097/QAD.0b013e32830f4c4d. No abstract available.

PMID:
18981761
15.

Delivery of antiretroviral therapy in sub-saharan Africa.

Weller I.

Clin Infect Dis. 2006 Sep 15;43(6):777-8. Epub 2006 Aug 8. No abstract available.

PMID:
16912955
16.

Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study.

Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ.

PLoS Med. 2010 Feb 9;7(2):e1000229. doi: 10.1371/journal.pmed.1000229.

17.

Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.

Hastings IM, Lalloo DG, Khoo SH.

AIDS. 2007 Jan 11;21(2):258-9; author reply 259-60. No abstract available.

PMID:
17197825
18.

Population effect of scaling up ART in resource-poor settings.

Egger M, Boulle A.

Lancet. 2008 May 10;371(9624):1558-9. doi: 10.1016/S0140-6736(08)60669-8. No abstract available.

PMID:
18468529
19.

Predicting the failure of 3 by 5.

[No authors listed]

Lancet. 2005 May 7-13;365(9471):1597. No abstract available.

PMID:
15889458
20.

HIV drugs for treatment, and for prevention.

Dabis F, Newell ML, Hirschel B.

Lancet. 2010 Jun 12;375(9731):2056-7. doi: 10.1016/S0140-6736(10)60838-0. Epub 2010 May 26. No abstract available.

PMID:
20537377

Supplemental Content

Support Center